By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists debate the structural advantages and risks of SPSM (S&P SmallCap 600) vs ISCB (iShares Core S&P Small-Cap ETF). Gemini and Claude disagree on the sustainability of SPSM's outperformance, with Gemini arguing that SPSM's quality filter protects against zombie small-caps, while Claude warns that this filter may fail in a recession. Grok and ChatGPT express neutral stances, highlighting potential risks and regime sensitivities.
Risk: The potential failure of SPSM's profitability screen in a recession, leading to increased tracking error and liquidity/tax costs.
Opportunity: SPSM's quality tilt and active management-like reconstitution process, which may protect against losses from unprofitable small-caps.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Comparing State Street SPDR Portfolio S&P 600 Small Cap ETF (NYSEMKT:SPSM) and iShares Morningstar Small-Cap ETF (NYSEMKT:ISCB) reveals a trade-off between the better recent performance of State Street fund and the much broader portfolio diversification offered by iShares.
Both funds provide core exposure to the U.S. small-cap market, yet they follow different indexing strategies. While the State Street fund focuses on a more curated list of 600 stocks, the iShares ETF casts a wider net, capturing over 1,500 companies within a similar sector framework.
| Metric | SPSM | ISCB | |---|---|---| | Issuer | SPDR | iShares | | Share price (as of June 26, 2026) | $57.30 | $74.93 | | Expense ratio | 0.03% | 0.04% | | 1-yr return (as of June 26, 2026)) | 36.9% | 30.7% | | Dividend yield | 1.4% | 1.3% | | Beta | 0.99 | 1.03 | | AUM | $16.9 billion | $285 million |
The funds’ expense ratios are basically the same (1 basis point doesn’t seem worth quibbling over). SPSM offers a slightly higher dividend yield of 1.4% versus 1.3% for ISCB.
| Metric | SPSM | ISCB | |---|---|---| | Max drawdown (5 yr) | (27.9%) | (29.9%) | | Growth of $1,000 over 5 years (total return) | $1,403 | $1,360 |
The iShares ETF tracks a broad benchmark of smaller U.S. companies, holding 1,586 securities. Its sector allocation is led by industrials at 18%, followed by technology at 16%, and financial services at 16%. Its largest positions include Sterling Infrastructure (NASDAQ:STRL) at 0.38%, Okta (NASDAQ:OKTA) at 0.33%, and Guardant Health (NASDAQ:GH) at 0.3%. The fund was launched in 2004. The ETF has paid $0.95 per share in dividends over the trailing 12 months, which on its recent ~$75 share price works out to a 1.3% yield.
The SPDR fund targets the S&P SmallCap 600 Index, holding 607 stocks. Its top sectors are technology at 17%, financial services at 17%, and industrials at 15%. Its largest positions include Formfactor (NASDAQ:FORM) at 0.64%, Molina Healthcare (NYSE:MOH) at 0.62%, and Brightspring Health Services (NASDAQ:BTSG) at 0.61%. The fund was launched in 2013. The ETF has paid $0.79 per share in dividends over the trailing 12 months, which on its recent ~$57 share price works out to a 1.4% yield.
For more guidance on ETF investing, check out the full guide at this link.
These two small-cap specialists have basically identical expense ratios, so I'm going to set that aside; it's not really relevant to this analysis.
ISCB is extremely diversified, holding more than twice as many stocks as its counterpart. That said, SPSM is not at all concentrated; no holding even approaches a 1% weighting in the portfolio. The iShares ETF is also very small relative to its SPDR counterpart, with assets under management of $285 million. Accordingly, it has very low average trading volume, and that type of limited liquidity may be a concern for some investors.
Finally, SPSM has posted better recent returns than ISCB. Past performance is no guarantee of future results, of course, but it's one more thing that tips the scale in favor of the SPDR ETF.
Before you buy stock in iShares Trust - iShares Morningstar Small-Cap ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $398,052! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,181,688!
Now, it’s worth noting Stock Advisor’s total average return is 892% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 30, 2026. *
Erin Kennedy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Guardant Health, Okta, and Sterling Infrastructure. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"SPSM's outperformance is a structural result of its profitability-weighted index methodology, which provides superior risk-adjusted exposure compared to the broader, lower-quality universe captured by ISCB."
The performance gap between SPSM and ISCB isn't just 'past performance'; it is a structural byproduct of the S&P SmallCap 600's profitability screen. Unlike the Morningstar index, which captures a wider, 'no-profit' tail of micro-caps, the S&P 600 requires companies to demonstrate positive earnings before inclusion. In a high-rate environment where the cost of capital remains elevated, this quality filter acts as a massive tailwind for SPSM. Investors chasing the 'small-cap rally' should recognize that ISCB is essentially buying a beta-heavy basket of speculative junk, while SPSM is effectively a quality-tilted factor fund. The liquidity difference is also stark; SPSM's $16.9B AUM ensures tighter bid-ask spreads compared to the thin liquidity of ISCB.
The very profitability filter that drives SPSM's outperformance could lead to significant underperformance during a sharp economic recovery, where speculative, non-profitable firms historically see the most aggressive multiple expansion.
"ISCB's $285M AUM creates material liquidity and survival risk that dwarfs any performance advantage SPSM currently enjoys, and the one-year return gap is likely mean-reverting noise rather than signal."
The article frames SPSM's 36.9% one-year return as outperformance, but this is a snapshot of a single year in a rising market—not evidence of structural superiority. SPSM's 607-stock S&P 600 index is *more concentrated by design* (top 3 holdings at ~1.9% combined vs ISCB's ~1% combined), which amplifies both upside and downside. The real red flag: ISCB's $285M AUM is dangerously small, creating liquidity risk and potential closure risk if flows deteriorate. The article acknowledges this but undersells it. Over 5 years, SPSM's $403 gain per $1K invested barely beats ISCB's $360—a 1.2% annualized difference that could easily reverse in a downturn given SPSM's higher beta (0.99 vs 1.03 is noise, but the drawdown data suggests SPSM held up better in 2020-2022, not necessarily going forward).
One year of outperformance in a small-cap rally doesn't prove SPSM is superior; the 5-year data shows ISCB's broader diversification (1,586 vs 607 stocks) may be the real edge in regime changes, and ISCB's lower max drawdown (-29.9% vs -27.9%) contradicts the article's claim of SPSM's 'better risk-adjusted growth.'
"SPSM's reported edge likely reflects the S&P 600 profitability filter more than any inherent ETF advantage."
The article positions SPSM as superior due to 36.9% one-year returns versus ISCB's 30.7%, tighter max drawdown, and $16.9B AUM, but glosses over the S&P 600's profitability screen that excludes unprofitable firms—unlike the broader Morningstar index. This construction difference likely explains recent outperformance in a quality-driven market, yet ISCB's 1,586 holdings could deliver better upside in speculative small-cap rallies. Low ISCB volume is a real liquidity flag, but SPSM's 607-stock concentration risks missing emerging names. Forward dates in the data also limit reliability.
If small-cap leadership rotates to unprofitable growth stocks, ISCB's wider net could reverse the performance gap quickly, making SPSM's edge cyclical rather than structural.
"The apparent outperformance of SPSM over ISCB is likely a short-term phenomenon; over a full market cycle, the broader diversification and liquidity of ISCB should provide more durable risk-adjusted returns."
Initial take: SPSM’s outperformance over ISCB is eye-catching—0.03% vs 0.04% expense, leaner ~600-stock roster, and a small tilt toward tech/financials. Yet the window is short; small caps swing a lot, and ISCB’s 1,500+ holdings offer genuine diversification and potentially lower idiosyncratic risk if a few names stumble. The article omits index methodology (S&P SmallCap 600 vs Morningstar small-cap benchmark), survivorship bias in reported returns, and liquidity dynamics given ISCB’s tiny AUM. With rates and cycles uncertain, a mean-reversion case favors the broader, more liquid approach even if SPSM has recent bragging rights.
The strongest counter is that this is likely a short-term window; over a full market cycle, ISCB’s broader diversification and greater liquidity would likely outperform SPSM during sector rotations and drawdowns.
"The S&P 600's committee-driven reconstitution provides a defensive quality advantage that ISCB's broader, passive index methodology cannot replicate."
Claude and Grok are fixated on the 'speculative rally' reversal, but they are ignoring the S&P 600's index reconstitution process. Unlike ISCB’s passive bucket, the S&P 600 committee actively removes companies that fail quality thresholds. This isn't just a 'profitability screen'; it's active management masquerading as passive. In a high-rate environment, the risk isn't just 'missing a rally'—it’s the permanent loss of capital from dead-weight, zombie small-caps that ISCB is forced to hold.
"S&P 600's quality filter is cyclical, not structural—it's a tailwind in expansions and a trap in recessions."
Gemini's 'active management masquerading as passive' framing is sharp, but overstates the risk. S&P 600 reconstitution removes *failing* companies—a feature, not a bug. The real question: does this quality filter persist through a recession? If small-cap earnings collapse uniformly, S&P 600's profitability screen becomes a liability, not protection. ISCB's 'zombie holdings' may actually outperform during distress when multiple compression hits quality names hardest. Nobody's priced in the regime where profitability filters fail.
"Quarterly reconstitutions add hidden turnover costs to SPSM that Claude's recession scenario overlooks."
Claude assumes uniform earnings collapse would hurt the profitability screen equally, but ignores S&P 600's quarterly reconstitutions that mechanically eject names before full distress, crystallizing losses via forced turnover. ISCB avoids this selling pressure entirely. The 2020-2022 drawdown edge for SPSM may not repeat if reconstitution timing amplifies tax drag and bid-ask costs during the next downturn.
"S&P 600 reconstitution is rules-based, but its edge may erode in downturns due to regime sensitivity and forced turnover."
Gemini, calling S&P 600 reconstitution 'active management' misreads the mechanics—it's rules-based and transparent, not a fund manager's discretion. The real risk isn't masquerade; it's regime sensitivity: in a broad earnings downturn, the profitability screen doesn't guarantee resilience and could widen tracking error vs ISCB as quality names hover near thresholds or get culled, forcing turnover. If that happens, the supposed edge fades just when liquidity and tax costs bite.
The panelists debate the structural advantages and risks of SPSM (S&P SmallCap 600) vs ISCB (iShares Core S&P Small-Cap ETF). Gemini and Claude disagree on the sustainability of SPSM's outperformance, with Gemini arguing that SPSM's quality filter protects against zombie small-caps, while Claude warns that this filter may fail in a recession. Grok and ChatGPT express neutral stances, highlighting potential risks and regime sensitivities.
SPSM's quality tilt and active management-like reconstitution process, which may protect against losses from unprofitable small-caps.
The potential failure of SPSM's profitability screen in a recession, leading to increased tracking error and liquidity/tax costs.